Transport of PIP3 by GAKIN, a kinesin-3 family protein, regulates neuronal cell polarity K Horiguchi, T Hanada, Y Fukui, AH Chishti The Journal of cell biology 174 (3), 425-436, 2006 | 165 | 2006 |
Evidence that a phosphatidylinositol 3, 4, 5-trisphosphate-binding protein can function in nucleus K Tanaka, K Horiguchi, T Yoshida, M Takeda, H Fujisawa, K Takeuchi, ... Journal of Biological Chemistry 274 (7), 3919-3922, 1999 | 150 | 1999 |
The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN/KIF13B KH Yamada, T Hanada, AH Chishti Biochemistry 46 (35), 10039-10045, 2007 | 89 | 2007 |
Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress KH Yamada, DA Kozlowski, SE Seidl, S Lance, AJ Wieschhaus, ... Journal of Biological Chemistry 287 (16), 13182-13193, 2012 | 81 | 2012 |
Phosphorylation-independent dual-site binding of the FHA domain of KIF13 mediates phosphoinositide transport via centaurin α1 Y Tong, W Tempel, H Wang, K Yamada, L Shen, GA Senisterra, ... Proceedings of the National Academy of Sciences 107 (47), 20346-20351, 2010 | 65 | 2010 |
KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2 KH Yamada, Y Nakajima, M Geyer, KK Wary, M Ushio-Fukai, Y Komarova, ... Journal of cell science 127 (20), 4518-4530, 2014 | 49 | 2014 |
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions NTT Nhàn, T Yamada, KH Yamada International Journal of Molecular Sciences 24 (16), 12931, 2023 | 25 | 2023 |
Antiangiogenic therapeutic potential of peptides derived from the molecular motor KIF13B that transports VEGFR2 to plasmalemma in endothelial cells KH Yamada, H Kang, AB Malik The American journal of pathology 187 (1), 214-224, 2017 | 16 | 2017 |
VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration SB Waters, C Zhou, T Nguyen, R Zelkha, H Lee, A Kazlauskas, ... Investigative ophthalmology & visual science 62 (2), 5-5, 2021 | 13 | 2021 |
Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides NTT Nhàn, DE Maidana, KH Yamada Cells 12 (7), 2023 | 12 | 2023 |
KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo SB Waters, JR Dominguez, HD Cho, NA Sarich, AB Malik, KH Yamada Life Science Alliance 5 (1), 2022 | 6 | 2022 |
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration KH Yamada Neural Regeneration Research 17 (8), 1751-1752, 2022 | 4 | 2022 |
KIF13B mediates VEGFR2 recycling to modulate vascular permeability HD Cho, NTT Nhàn, C Zhou, K Tu, T Nguyen, NA Sarich, KH Yamada Cellular and Molecular Life Sciences 80 (4), 91, 2023 | 1 | 2023 |
Anti‐angiogenic Peptide Derived from Kinesin KIF13B Inhibits Trafficking of VEGFR2 to Endothelial Cell surface K Yamada, AB Malik The FASEB Journal 31, 990.8-990.8, 2017 | 1 | 2017 |
驱动蛋白源性血管生成抑制剂可选择性抑制 VEGFR2 向细胞表面运输 KH Yamada 中国神经再生研究 (英文版) 17 (8), 1751, 2022 | | 2022 |
KIF13B-derived peptide and method of inhibiting angiogenesis K Yamada, A Malik US Patent 11,299,524, 2022 | | 2022 |
A kinesin mediates VEGFR2 recycling and regulates VE-cadherin phosphorylation, essential for vascular permeability HD Cho, C Zhou, K Tu, T Nguyen, NA Sarich, KH Yamada bioRxiv, 2022.06. 06.494986, 2022 | | 2022 |
VEGFR2 trafficking by KIF13B is a novel therapeutic target for wet AMD K Yamada, C Zhou Investigative Ophthalmology & Visual Science 62 (8), 220-220, 2021 | | 2021 |
Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells (vol 187, pg 214, 2017) KH Yamada, H Kang, AB Malik AMERICAN JOURNAL OF PATHOLOGY 188 (8), 1934-1934, 2018 | | 2018 |
Role of kinesin-mediated transport of VEGFR2 to the cell surface in mediating angiogenesis. K Yamada, GF Chen, H Gong, Y Komarova, M Ushio-Fukai, K Wary, ... MOLECULAR BIOLOGY OF THE CELL 22, 2011 | | 2011 |